GeekWire Opens Nominations for 2025 Uncommon Thinkers Awards Honoring Seattle Innovators
GeekWire has opened nominations for its 2025 Uncommon Thinkers Awards, recognizing Seattle-area innovators advancing technology and society. Honorees will be selected by judges and celebrated at the GeekWire Gala on December 11, 2024.
GeekWire Podcast Features Seattle’s ‘Uncommon Thinkers’ Innovators Honored at Annual Gala
The GeekWire Podcast highlights Seattle's 'Uncommon Thinkers,' including innovators like Uri Shumlak of Zap Energy and Ingrid Swanson Pultz of Mopac Biologics, recognized at the GeekWire Gala for transforming industries with novel approaches.
Takeda buys Seattle startup PvP Biologics for up to $330M, will advance TAK-062 into Phase 2
Japanese pharmaceutical Takeda acquired Seattle biotech PvP Biologics for up to $330 million in late February, taking over its TAK-062 (Kuma062) program and all clinical and manufacturing activities while laying off PvP staff. Takeda plans to run phase 2 trials of the enzyme-based celiac disease treatment that PvP developed after earlier funding of $35 million supported phase 1 work.
Organizations
-
Mopac Chief Technology Officer · current
-
Mopac Biologics CTO and Translational Advisor · current
-
University of Washington Protein Design Researcher · current